Thursday, October 15, 2020 10:18:31 AM
good morning,
Both the death cross and the golden cross carry a lot of weight for me as a simple get in /get out indicator.
The investor attitude of "i made a mistake and will take my loss" seems to me what is happening. No one likes a loss but its easier to swallow aa small loss then get locked in with a large loss. Right now it is a steady drip of investors selling.
My fear is that the slow leak will will accelerate with time especially that we are now in the fourth quarter and many investors might have large profits to offset.
The group of investors that bought at $8.0 in the recent offering can not be happy. There is the larger group of investors that bought Andy Sealfons stock and have seen their profit almost cut in half. Do they take money off the take or wait? Too many people looking to the exit.
There can also be margin calls and shorting going on.
Price evaluation is difficult, even with a great story such as KRMD, against a market heading south
Just how i see things.
Both the death cross and the golden cross carry a lot of weight for me as a simple get in /get out indicator.
The investor attitude of "i made a mistake and will take my loss" seems to me what is happening. No one likes a loss but its easier to swallow aa small loss then get locked in with a large loss. Right now it is a steady drip of investors selling.
My fear is that the slow leak will will accelerate with time especially that we are now in the fourth quarter and many investors might have large profits to offset.
The group of investors that bought at $8.0 in the recent offering can not be happy. There is the larger group of investors that bought Andy Sealfons stock and have seen their profit almost cut in half. Do they take money off the take or wait? Too many people looking to the exit.
There can also be margin calls and shorting going on.
Price evaluation is difficult, even with a great story such as KRMD, against a market heading south
Just how i see things.
Recent KRMD News
- KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026 • Business Wire • 04/16/2026 12:00:00 PM
- KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility • Business Wire • 03/13/2026 12:00:00 PM
- KORU Medical Systems Announces CEO Transition • Business Wire • 03/12/2026 08:08:00 PM
- KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance • Business Wire • 03/12/2026 08:05:00 PM
- KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 • Business Wire • 02/26/2026 09:05:00 PM
- KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System • Business Wire • 01/29/2026 09:05:00 PM
- KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow • Business Wire • 01/12/2026 01:00:00 PM
- KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 01/05/2026 12:00:00 PM
- KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic • Business Wire • 12/30/2025 09:05:00 PM
- KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer • Business Wire • 12/16/2025 09:05:00 PM
- KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025 • Business Wire • 11/17/2025 09:05:00 PM
- KORU Medical Systems to Participate in Upcoming Investor Conferences • Business Wire • 11/13/2025 01:00:00 PM
- KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance • Business Wire • 11/12/2025 09:05:00 PM
- KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems • Business Wire • 11/04/2025 09:05:00 PM
- KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025 • Business Wire • 10/22/2025 08:05:00 PM
- ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy • Business Wire • 09/18/2025 12:00:00 PM
- Cirtec Medical Announces Appointment of New Chief Executive Officer • GlobeNewswire Inc. • 08/28/2025 04:59:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2025 08:26:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2025 08:24:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2025 08:23:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2025 03:18:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2025 08:11:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2025 08:08:43 PM
- KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance • Business Wire • 08/06/2025 08:05:00 PM
- KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 08/01/2025 08:55:00 PM
